看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | -2.5x - -2.8x | -2.7x |
| Selected Fwd EBIT Multiple | -3.3x - -3.7x | -3.5x |
| Fair Value | €2.69 - €2.93 | €2.81 |
| Upside | 0.4% - 9.5% | 4.9% |
| Benchmarks | Ticker | Full Ticker |
| Abbott Laboratories | ABT | NYSE:ABT |
| Healthcare Triangle, Inc. | HCTI | NasdaqCM:HCTI |
| JRSIS Health Care Corporation | JRSS | OTCPK:JRSS |
| SCWorx Corp. | WORX | NasdaqCM:WORX |
| CareView Communications, Inc. | CRVW | OTCPK:CRVW |
| SOPHiA GENETICS SA | 90B | BST:90B |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| ABT | HCTI | JRSS | WORX | CRVW | 90B | ||
| NYSE:ABT | NasdaqCM:HCTI | OTCPK:JRSS | NasdaqCM:WORX | OTCPK:CRVW | BST:90B | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | 9.5% | NM- | NM- | NM- | NM- | NM- | |
| 3Y CAGR | -6.6% | NM- | NM- | NM- | NM- | NM- | |
| Latest Twelve Months | 14.8% | 1.2% | -68.0% | -15.1% | -264.7% | 2.7% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 19.1% | -18.9% | 0.9% | -69.0% | -19.2% | -143.2% | |
| Prior Fiscal Year | 18.0% | -18.0% | -39.8% | -38.1% | -7.1% | -119.9% | |
| Latest Fiscal Year | 17.9% | -40.6% | -5.4% | -42.1% | -19.1% | -102.1% | |
| Latest Twelve Months | 19.3% | -39.3% | -19.5% | -48.8% | -17.8% | -96.6% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 5.57x | 1.85x | 0.73x | 0.06x | 3.72x | 2.64x | |
| EV / LTM EBITDA | 21.0x | -5.1x | -4.1x | NA | -24.1x | -2.8x | |
| EV / LTM EBIT | 28.9x | -4.7x | -3.8x | -0.1x | -20.9x | -2.7x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -20.9x | -3.8x | 28.9x | ||||
| Historical EV / LTM EBIT | -10.2x | -2.4x | 0.4x | ||||
| Selected EV / LTM EBIT | -2.5x | -2.7x | -2.8x | ||||
| (x) LTM EBIT | (67) | (67) | (67) | ||||
| (=) Implied Enterprise Value | 171 | 180 | 189 | ||||
| (-) Non-shareholder Claims * | 31 | 31 | 31 | ||||
| (=) Equity Value | 202 | 211 | 220 | ||||
| (/) Shares Outstanding | 67.6 | 67.6 | 67.6 | ||||
| Implied Value Range | 2.99 | 3.12 | 3.26 | ||||
| FX Rate: USD/EUR | 1.2 | 1.2 | 1.2 | Market Price | |||
| Implied Value Range (Trading Cur) | 2.57 | 2.68 | 2.80 | 2.68 | |||
| Upside / (Downside) | -4.1% | 0.1% | 4.4% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | ABT | HCTI | JRSS | WORX | CRVW | 90B | |
| Enterprise Value | 239,518 | 21 | 3 | 0 | 31 | 180 | |
| (+) Cash & Short Term Investments | 7,282 | 7 | 0 | 1 | 1 | 95 | |
| (+) Investments & Other | 643 | 0 | 0 | 0 | 0 | 0 | |
| (-) Debt | (13,470) | (1) | (1) | (0) | (21) | (64) | |
| (-) Other Liabilities | (264) | 0 | 0 | 0 | 0 | 0 | |
| (-) Preferred Stock | 0 | (7) | 0 | (0) | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 233,709 | 20 | 1 | 1 | 11 | 211 | |
| (/) Shares Outstanding | 1,740.5 | 5.8 | 84.6 | 3.6 | 583.9 | 67.6 | |
| Implied Stock Price | 134.28 | 3.35 | 0.01 | 0.30 | 0.02 | 3.12 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.16 | |
| Implied Stock Price (Trading Cur) | 134.28 | 3.35 | 0.01 | 0.30 | 0.02 | 2.68 | |
| Trading Currency | USD | USD | USD | USD | USD | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.16 | |